(2015) AASLD guidelines for treatment of chronic hepatitis B. Hepatology , n/a-n/a /Terrault NA, Bzowej NH, Chang KM, Hwang JP, Jonas MM, Murad MH. AASLD guidelines for treatment of chronic hepatitis B. Hepatology 2016; 63:261-83....
1．Terrault NA, Lok ASF, McMahon BJ, et al. Update on prevention, diagnosis, and treatment of chronic hepatitis B: AASLD 2018 hepatitis B guidance. Hepatology. 2018;67(4):1560-1599.2．Heimbach JK, Kulik LM, Finn RS, et al. AASLD guidelines for the treatment of hepatocellular carcinoma....
[5] Guidelines for the prevention and treatment of chronic hepatitis B (version 2022). Zhonghua Gan Zang Bing Za Zhi 2022;30(12):1309-1331. doi: 10.3760/cma.j.cn501113-20221204-00607. PMID: 36891718 [6] Standa...
which can lead to ascites and volume overload. A common diuretic regimen for these patients includes furosemide and spironolactone. According to the American Association for the Study of Liver Diseases (AASLD) guidelines, initiating bo...
525.22K 文档页数: 34页 顶/踩数: 2/0 收藏人数: 0 评论次数: 0 文档热度: 文档分类: 行业资料--畜牧 系统标签: aasld英文版乙肝hepatitisentecavirtelbivudine AASLDPRACTICEGUIDELINE CorrectionstoAASLDGuidelinesonChronicHepatitisB TotheEditor: WewouldappreciateifcorrectionstoTables2and10 inLokandMcMahon(HEPATOL...
Journal of Clinical HepatologyXU Ying,LIU Yu,SUN Jian.,.Key points of the AASLD's guidelines on hepatitis B diagnosis and treatment.[J];Journal of Clinical Hepatology,2013-02XU Ying,LIU Yu,SUN Jian.,.Key points of the AASLD's guidelines on hepatitis B diagnosis and treatment.[J];临床...
内容提示: Hepatitis C Guidance 2023 Update: American Association for the Study of Liver Diseases– Infectious Diseases Society of America Recommendations for Testing, Managing, and Treating Hepatitis C Virus Infection Debika Bhattacharya, 1, Andrew Aronsohn, 2 Jennifer Price, 3 and Vincent Lo Re III...
EASL Clinical Practice Guidelines: Management of Chronic Hepatitis B. In Press 总结(1) ? 替比夫定对慢性乙型肝炎抗病毒治疗疗效是满意的 HBeAg(+)患者24周有45%HBVDNA检测不到 2年有88%HBVDNA检测不到 e 抗原血清转换可达29% 3年e抗原消失可达56% ...
美国肝病研究协会(AASLD)慢乙肝指南 优化慢乙肝治疗策略的展望 •用更好的治疗手段以获得停药后疾病持续缓解,–乙肝病毒e抗原(HBeAg)血清转换–乙肝病毒(HBV)DNA检测不到–乙肝病毒表面抗原(HBsAg)血清转换缩短治疗时间，减少不良反应降低核苷类似物耐药风险 •采用标准方法定量检测病毒抗原•更个体化的治疗乙肝•...
美国肝病研究协会（AASLD）慢乙肝指南 海南中医药研究所附属琼岛医院肝病中心 优化慢乙肝治疗策略的展望 •用更好的治疗手段以获得停药后疾病持续缓解,–乙肝病毒e抗原(HBeAg)血清转换–乙肝病毒(HBV)DNA检测不到–乙肝病毒表面抗原(HBsAg)血清转换缩短治疗时间，减少不良反应降低核苷类似物耐药风险 •采用标准方法定量...